Eye care chain Disha Medical Services raises over Rs 27 crore in Series C funding

Published On 2019-06-12 04:15 GMT   |   Update On 2019-06-12 04:15 GMT

Exiting investor Lok advised fund - Sarva Capital has been provided with a full exit as part of the current fundraising, Disha Medical Services said in a statement.


New Delhi: Eye care firm Disha Medical Services Tuesday said it has raised Series C funding of USD 4 million (over Rs 27 crore) from Insitor Impact Asia Fund, the Nilekani Family Office and other high net worth individuals.


Exiting investor Lok advised fund - Sarva Capital has been provided with a full exit as part of the current fundraising, Disha Medical Services said in a statement.


The company will use the current round of capital to further strengthen its position in the existing regions by building over 10 more hospitals, vision centres and mobile eye clinics and will also look to expand strategically in other states, it added.


Read Also: Healthcare Startup Pristyn Care raises Rs 27 crore funding from Sequoia India

Commenting on the development, Disha Medical Services co-founder Anjali Joshi said: "We will focus on empowering more ophthalmologists with advanced infrastructure and processes that help them deliver high-quality care in our markets."


The company currently manages 6 eye hospitals, 6 mobile eye clinics and 4 vision centres across various towns of Karnataka.

The Nilekani Family Office in a statement said it believes in the vision of Disha Medical Services and its founders of providing affordable eye care and will continue to support the company as it ramps up operations.


Read Also: Medikabazaar to raise Rs 200 crore in Series B funding
Article Source : PTI

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News